Literature DB >> 809438

Covalently bound FAD in d-6-hydroxynicotine oxidase. Immunological studies of D- and L-6-hydroxynicotine oxidase: evidence for a D-enzyme precursor.

M Brühmüller, A Schimz, L Messmer, K Decker.   

Abstract

Antersera prepared against both enantiozymes, D- and L-6-hydroxynicotine oxidase, formed precipitins in double diffusion tests with their respective antigens only. A mixture of the two antisera caused spur formation of the two precipitin lines obtained with the pure enzymes. Antiserum to L-apoprotein reacted with native L-enzyme and L-apoprotein but not with the D-sspecific enzyme. D-6-hydroxynicotine oxidase activity was inhibited by the anti-D-antiserum, leaving the L-enzyme fully active, while anti-L-antiserum inhibited the L- but not the D-specific activity. The delayed induction of D-6-hydroxynicotine oxidase as compared to the other activities of the nicotine-degrading sequence and the differential immunochemical behavior of the enantiozymes allowed the search for a D-enzyme precursor. In cells harvested 3 hours after the addition of DL-nicotine, the L-enzyme activity was present, whereas no D-enzyme activity could be detected. However, an extract of these cells did form an immunoprecipitin line with anti-D-antiserum. L-6-Hydroxynicotine oxidase, but no D-6-hydroxynicotine oxidase activity, could also be induced in Arthrobacter oxidans grown in a medium with a high glucose content and DL-nicotine as the sole nitrogen source. An extract of these L-induced cells produced the specific immunoprecipitation with anti-D-antiserum. A pulse-chase experiment with cells grown first on glucose and DL-nicotine in the presence of [14C]leucine and then in an unlabeled medium which induces D-6-hydroxynicotine oxidase activity resulted in a radioactive D-enzyme-immunoprecipitin line. From these experiments it is concluded that a precursor of the active D-enzyme is induced simultaneously with the other nicotine-degrading enzymes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 809438

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Characterization of PmfR, the transcriptional activator of the pAO1-borne purU-mabO-folD operon of Arthrobacter nicotinovorans.

Authors:  Calin B Chiribau; Cristinel Sandu; Gabor L Igloi; Roderich Brandsch
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

2.  A functional mobA gene for molybdopterin cytosine dinucleotide cofactor biosynthesis is required for activity and holoenzyme assembly of the heterotrimeric nicotine dehydrogenases of Arthrobacter nicotinovorans.

Authors:  Paula Sachelaru; Emile Schiltz; Roderich Brandsch
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

3.  Regulation of flavoprotein synthesis studied in vivo in a riboflavin-requiring mutant of Arthrobacter oxidans.

Authors:  H H Hamm; K Decker
Journal:  Arch Microbiol       Date:  1978-10-04       Impact factor: 2.552

4.  Induction of D-6-hydroxynicotine oxidase in resting cells of Arthrobacter oxidans.

Authors:  H C Reeves; L Messmer; K Decker
Journal:  Arch Microbiol       Date:  1976-12-01       Impact factor: 2.552

5.  Plasmid pAO1 of Arthrobacter oxidans encodes 6-hydroxy-D-nicotine oxidase: cloning and expression of the gene in Escherichia coli.

Authors:  R Brandsch; W Faller; K Schneider
Journal:  Mol Gen Genet       Date:  1986-01

6.  An NAD(P)H-nicotine blue oxidoreductase is part of the nicotine regulon and may protect Arthrobacter nicotinovorans from oxidative stress during nicotine catabolism.

Authors:  Marius Mihasan; Calin-Bogdan Chiribau; Thorsten Friedrich; Vlad Artenie; Roderich Brandsch
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

7.  The effect of gyrase inhibitors and cyclic AMP on induction and glucose repression of the 6-hydroxy-nicotine oxidases in Arthrobacter oxidans.

Authors:  R Brandsch; K Decker
Journal:  Arch Microbiol       Date:  1982-12-03       Impact factor: 2.552

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.